Ventricular septal rupture following abciximab infusion
Jayanth R Arnold1, Jonathan Timperley, Andrew R J Mitchell
1Department of Cardiology, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK. ranjitarnold@yahoo.co.uk
Summary
Ventricular septal rupture, a rare myocardial infarction complication, can occur after abciximab treatment. This case highlights potential risks of glycoprotein IIb-IIIa receptor blockers, even without thrombolysis.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Medical Research
Background:
- Ventricular septal rupture is a rare but serious complication following myocardial infarction.
- Reperfusion therapy has reduced the incidence of septal rupture, but thrombolysis is implicated in its pathogenesis.
- Limited data exists on the impact of glycoprotein IIb-IIIa receptor blockers on ventricular septal rupture.
Observation:
- A case of ventricular septal rupture occurred in a patient treated with abciximab, a glycoprotein IIb-IIIa receptor blocker.
- The patient did not receive thrombolysis, suggesting an alternative mechanism for septal rupture.
Findings:
- Glycoprotein IIb-IIIa receptor blockers, such as abciximab, may be associated with the development of ventricular septal rupture.
- This association may exist independently of thrombolytic therapy.
Implications:
- Clinicians should be aware of the potential risk of ventricular septal rupture when using abciximab, particularly in myocardial infarction patients.
- Further research is needed to elucidate the mechanisms linking glycoprotein IIb-IIIa receptor blockers to septal rupture.
- This finding may influence treatment strategies and patient monitoring in acute myocardial infarction management.
Related Concept Videos
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:30Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...